C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 110 filers reported holding C4 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,671,000 | -24.7% | 481,094 | 0.0% | 2.61% | -27.3% |
| Q4 2021 | $15,491,000 | -27.9% | 481,094 | 0.0% | 3.59% | -36.7% |
| Q3 2021 | $21,495,000 | +18.1% | 481,094 | 0.0% | 5.67% | -10.7% |
| Q2 2021 | $18,205,000 | +2.3% | 481,094 | 0.0% | 6.34% | -10.5% |
| Q1 2021 | $17,795,000 | +11.6% | 481,094 | 0.0% | 7.09% | -18.2% |
| Q4 2020 | $15,939,000 | – | 481,094 | – | 8.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |